Impairment of Brucella growth in human macrophagic cells that produce nitric oxide

Microbial Pathogenesis

Volumn 36, Issue 2, 2004, Pages 75-82

  Gross, Antoine ^a   Bertholet, Sylvie ^b   Mauel, Jacques ^b   Dornand, Jacques ^a  

^a INSERM   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Brucella; Human macrophages; Infection; Nitric oxide

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; MEMBRANE RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BIOENGINEERING; BRUCELLA; BRUCELLOSIS; CELL ACTIVATION; CELL ISOLATION; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MACROPHAGE; MODEL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL;

BRUCELLA;

EID: 0346218241     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2003.09.003     Document Type: Article

References (42)

1. Corbel M.J. Brucella. Parker T., Collier L.H. Principles of bacteriology, virology and immunity. vol. 2:1990;341-353 Edward Arnold, London.
2. Enright F.M. The pathogenesis and pathobiology of Brucella infection in domestic animals. Nielsen K., Duncan J.R. Animal brucellosis. 1990;301-320 CRC Press, Boston.
3. Garcia-Carrillo C. Laboratory animal models for brucellosis studies. Nielsen K., Duncan J.R. Animal brucellosis. 1990;423-442 CRC Press, Boston.
4. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 15:1997;323-350.
5. Schneemann M., Schoedon G. Species differences in macrophage NO production are important. Nat Immunol. 3:2002;102.
6. Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2:2001;907-916.
7. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 55:1994;682-684.
8. Albina J.E. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol. 58:1995;682-684.
9. Dugas B., Mossalayi M.D., Damais C., Kolb J.P. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today. 16:1995;574-580.
10. DeMaria R., Cifone M.G., Trotta R., Rippo M., Festuccia A., Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med. 180:1994;1999-2004.
11. Bukrinsky M.I., Nottet H.S., Schmidtmayerova H., Dubrovsky L., Flanagan C.R., Mullins M.E., Lipton S.A., Gendelman H.E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type1 (HIV-1)-infected monocytes: implications for HIV1-associated neurological disease. J Exp Med. 181:1995;735-745.
12. Rocket K.A., Brookes R., Udalova I., Vidal V., Hill A.S.V., Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 66:1998;5314-5321.
13. Dugas N., Mossalayi M.D., Calenda A., Leotard A., Becherel P., Mentz F., Ouaaz F., Arock M., Debre P., Dornand J., Dugas B. Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells. Blood. 88:1996;3528-3534.
14. Weinberg J.B. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med. 4:1998;557-591.
15. Zhan Y., Cheers C. Control of IL-12 and IFN-γ production in response to live or dead bacteria by TNF and other factors. J Immunol. 161:1998;1447-1453.
16. Zhan Y., Liu Z., Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun. 64:1996;2782-2786.
17. Ko J., Gendron-Fitzpatrick A., Splitter G.A. Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis. J Immunol. 168:2002;2433-2440.
18. Gross A., Speisser S., Terraza A., Rouot B., Caron E., Dornand J. Expression and bactericidal activity of nitric oxide synthase in Brucella suis infected murine macrophages. Infect Immun. 66:1998;1309-1316.
19. Eze M.O., Yuan L., Crawford R.M., Paranavitana C.M., Hadfield T.L., Bhattacharjee A.K., Warren R.L., Hoover D.L. Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro. Infect Immun. 68:2000;257-263.
20. Jiang X., Leonard B., Benson R., Baldwin C.L. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell Immunol. 151:1993;309-319.
21. Lopez-Urrutia L., Alonso A., Nieto M.L., Bayon Y., Orduna A., Sanchez-Crespo M. Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages. Infect Immun. 68:2000;1740-1745.
22. Caron E., Liautard J.P., Köhler S. Differentiated U-937 exhibit increased bactericidal activity upon LPS activation and discriminate between virulent and avirulent Listeria and Brucella species. J Leukoc Biol. 56:1994;174-181.
23. Reiling N., Ulmer A.J., Duchrow M., Ernst M., Flad H.D., Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 24:1994;1941-1944.
24. Gross A., Dugas N., Spiesser S., Vouldoukis I., Damais C., Kolb J.P., Dugas B., Dornand J. Nitric oxide production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization by measurement of the luminol dependent chemiluminescence. Free Radic Res. 28:1998;179-191.
25. Fukuda K., Akao S., Ohno Y., Yamashita K., Fujiwara H. Inhibition by costunolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Cancer Lett. 164:2001;7-13.
26. Cameron M.L., Granger D.L., Weinberg J.B., Korumbo W.J., Koren H.S. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis. 142:1990;1313-1319.
27. Schoedon G., Scheemann M., Walter R., Blau N., Hofer S., Schaffner A. Nitric oxide and infection: another view. Clin Infect Dis. 21:(Suppl. 2):1995;S152-S157.
28. Caron E., Peyrard T., Köhler S., Cabane S., Liautard J.P., Dornand J. Live Brucella spp. fail to induce TNF-α excretion in U-937-derived phagocytes. Infect Immun. 62:1994;5267-5274.
29. Caron E., Gross A., Liautard J.P., Dornand J. Brucella spp. release a specific, protease-sensitive, inhibitor of TNF-α expression, active on human but not on murine macrophage-like cells. J Immunol. 156:1996;2885-2893.
30. Jubier-Maurin V., Boigesgrain R.A., Cloeckaert A., Gross A., Alvarez-Martinez M.T., Terraza A., Liautard J.P., Kohler S., Rouot B., Dornand J., Liautard J.P. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect Immun. 69:2001;4823-4830.
31. Bertholet S., Tzeng E., Felley-Bosco E., Mauel J. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol. 65:1999;50-58.
32. Bertholet S., Mauel J. Human monocytic U937 cells transfected with human hepatic inducible nitric oxide synthase exhibit leishmanicidal activity. J Leukoc Biol. 67:2000;34-39.
33. Vouldoukis I., Riveros-Moreno V., Dugas B., Ouaaz F., Becherel P., Debre P., Moncada S., Mossalayi M.D. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci USA. 92:1995;7804-7808.
34. Escande A., Serre A. IgE anti-brucella antibodies in the course of human brucellosis and after specific vaccination. Int Arch Allergy Appl Immunol. 68:1982;172-175.
35. Araj G.F., Lulu A.R., Khateeb M.I., Haj M. Specific IgE response in patients with brucellosis. Epidemiol Infect. 105:1990;571-577.
36. Schneemann M., Schoedon G., Hofer S., Blau N., Guerrero L., Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 167:1993;1358-1363.
37. Wang M., Qureshi N., Soeurt N., Splitter G. High levels of nitric oxide production decrease early but increase late survival of Brucella abortus in macrophages. Microb Pathog. 31:2001;221-230.
38. Gobert A.P., Daulouede S., Lepoivre M., Boucher J.L., Bouteille B., Buguet A., Cespuglio R., Veyret B., Vincendeau P. L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immun. 68:2000;4653-4657.
39. Nicholson S., Bonecini-Almeida Mda G., Lapa e Silva J.R., Nathan C., Xie Q.W., Mumford R., Weidner J.R., Calaycay J., Geng J., Boechat N. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 183:1996;2293-2302.
40. Sharara A.I., Perkins D.J., Misukonis M.A., Chan S.U., Dominitz J.A., Weinberg J.B. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med. 186:1997;1495-1502.
41. Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfati M., Hofstetter H., Kilcherr E., Debre P., Dalloul A. Expression, structure, and function of the CD23 antigen. Adv Immunol. 49:1991;149-191.
42. Aubry J.P., Pochon S., Graber P., Jansen K.U., Bonnefoy J.Y. CD21 is a ligand for CD23 and regulates IgE production. Nature. 358:1992;505-507.